Table_1_Predictive Value of Free Triiodothyronine to Free Thyroxine Ratio in Euthyroid Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.docx by Side Gao (9122978)

“…</p>Methods<p>A total of 1162 euthyroid patients with MINOCA were enrolled and divided according to decreased tertiles of fT3/fT4 ratio. …”

Lectin Complement Protein Collectin 11 (CL-K1) and Susceptibility to Urinary Schistosomiasis by Justin S. Antony (711810)

“…Higher CL-K1 serum levels were associated with decreased risk of schistosome infection (<i>P^corr</i> = 0.0004). …”

Maximum deformability (EI max) after RBC incubation with RBC-NOS stimulants, inhibitors and NO controls and correlation of EI max with S-nitrosylation of α- and β-spectrin. by Marijke Grau (284060)

“…<p>(A) Bars show that EI max significantly increased after 60 min incubation with L-arginine (P<0.05), insulin (P<0.05) and SNP (P<0.05). …”

Data_Sheet_1_Effects of replacing wheat bran with palm kernel cake or fermented palm kernel cake on the growth performance, intestinal microbiota and intestinal health of tilapia (... by Huajing Huang (18002284)

“…Complete replacement with PKC significantly decreased the activity of lipase and trypsin, and reduced the height of muscularis and the height of villus (p < 0.05). …”

Evolution of DLCO during the follow up. by Noémie Le Gouellec (4318939)

“…DLCO significantly decreased over time (-1.5±0.3%/year (p<0.0001). Panel B is the progression-free survival of DLCO. …”

Trabecular bone formation rates are lower in <i>Hdac3</i> CKO mice. by David F. Razidlo (230381)

“…<p>A Fluorochrome incorporation in the trabeculi of distal femurs is decreased in CKO mice. …”

Global structural model fit statistics and path coefficients. by Ashkan Hassani (16406616)

“…Unit change represents the b-coefficient value multiplied by the standard deviation of the outcome variable (i.e., people per room standard deviation = 0.98 multiplied by a standardized coefficient of 0.18 results in a 0.18-point increase [0.98 x 0.18] in reported poor emotional health).…”

SBDS expression is downregulated during PLB-985 neutrophil differentiation. by Claudia Orelio (217728)

“…(C) Western blot analysis for SBDS expressing levels and actin as a protein loading control in undifferentiated (day 0) and differentiating (day 3–7) PLB-985 cells shows that SBDS protein expression decreases during neutrophil differentiation (representative for n = 5 independent cellular differentiation experiments). …”

Effects of ketamine and the established GSK-3 inhibitor SB216763 in the CMS model. by Xian-Cang Ma (285384)

“…(<b>B</b>) Tail-suspension test (TST): The increased immobility time of mice in the CMS groups, decreased significantly 48 hours (day 38) after a single dose of ketamine (10 mg/kg, i.p.), but not SB216763 (10 mg/kg, i.p.). …”

Valve opening duration (VOD) and amplitude (VOA). by Laura Payton (4506571)

“…(A3) Seasonal histograms of VOD. Letters indicate significant differences (one-way analysis of variance, <i>p</i> < 0.05). …”

Table 2_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

“…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”

Data Sheet 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

“…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”

Table 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

“…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”

Model results under different levels of extrinsic mortality. by Boris H. Kramer (402393)

“…In C)–F) the solid lines indicate the results when the optimal values of and , The dashed lines indicate results if the colony did not change the maintenance investments () or the switching time () with increasing extrinsic mortality ( = 0.38  = 84). A) Optimal investment into workers () decreases with increasing extrinsic risk. …”

FIG. S2 by Bo Guo (1559695)

“…The normalized vector potential a0 decreases to 1.85 for the 0.5-mm jet and 1.67 for the 1-mm jet. …”

Compounds of lipid metabolism with altered levels of abundance in <i>Ubi</i> > <i>bmm-RNAi</i> flies. by Nestor O. Nazario-Yepiz (4386478)

“…Red and dark blue represent the metabolites that increased and decreased respectively at <i>p</i> ≤ 0.05, light red and light blue represent the metabolites that increased and decreased respectively at 0.05 ≤ <i>p</i> ≤ 0.1 (q-value is reported in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0255198#pone.0255198.s014" target="_blank">S1 Dataset</a>). …”

NUMB is an OSCC suppressor. by Pei-Shi Hung (489732)

“…<p>(A) Exogenous expression of NUMB decreases the oncogenicity of SAS cells. …”

DataSheet_1_Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.pdf by Wentao Yang (205781)

“…Moreover, patients with RAS mutations tended to have a worse prognosis (P = 0.072).</p>Conclusions<p>This study demonstrates that ctDNA is a promising biomarker for monitoring the dynamic response to treatment and determining the prognosis of mCRC.…”

DataSheet_1_Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.pdf by Wentao Yang (205781)

“…Moreover, patients with RAS mutations tended to have a worse prognosis (P = 0.072).</p>Conclusions<p>This study demonstrates that ctDNA is a promising biomarker for monitoring the dynamic response to treatment and determining the prognosis of mCRC.…”

Gait abnormalities and hyperlocomotion. by Annette E. Rünker (195285)

“…(B) There is a trend towards decreased hind-front overlap in <i>Sema6A^−/−</i> mutants (p = 0.07). …”